2nd June 2017
Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")
Top Ten Equity Holdings and Sector and Geographic Exposure as at 31st May 2017 and full Portfolio listing as at 28th April 2017 available from company's website
Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 31st May 2017 the top ten equity holdings and the sector and geographic breakdown were as follows:
Top 10 Holdings |
% |
Merck & Co |
7.4% |
Pfizer |
7.1% |
Johnson & Johnson |
6.3% |
Sanofi |
5.7% |
GlaxoSmithKline |
5.3% |
Novartis |
4.8% |
Merck KGaA |
4.5% |
Roche |
4.2% |
Astellas Pharma |
3.3% |
Bristol Myers Squibb |
3.2% |
Total |
51.8% |
Sector Exposure |
% |
Pharmaceuticals |
60.4% |
Healthcare Equipment |
9.5% |
Healthcare REITs |
5.5% |
Biotechnology |
4.7% |
Healthcare Services |
4.5% |
Managed Healthcare |
3.4% |
Healthcare Facilities |
3.3% |
Healthcare Supplies |
1.7% |
Life Sciences Tools & Services |
0.6% |
Life & Health Insurance |
0.6% |
Healthcare Distributors |
0.1% |
Cash |
5.6% |
Total |
100.0% |
Geographic Exposure |
% |
United States |
46.3% |
United Kingdom |
11.1% |
Switzerland |
9.8% |
Japan |
5.7% |
France |
5.7% |
Germany |
5.1% |
Ireland |
3.6% |
Australia |
2.8% |
Canada |
1.8% |
Denmark |
0.9% |
India |
0.7% |
Italy |
0.7% |
Norway |
0.3% |
Cash |
5.6% |
Total |
100% |
The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.com
Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.
